Abstract:Background: Angiotensin I-converting enzyme (ACE) inhibitory peptide has good effect on blood pressure regulation. Therefore, research to find and develop safer, effective and economical ACE inhibitors is necessary for the prevention and remedy of hypertension. So food-derived ACE inhibitory peptides isolated from food or from enzymatic digestion of food proteins are the safe and efficient substitution for human health.Objective: To investigate the effect of rice dreg enzymatic hydrolysates as an anti-hypertensive in vivo with spontaneous hypertension rats (SHRs).Design: The once-oral administration experiments with rice dreg hydrolysates peptide (RDHP) in different doses were conducted using 6 weeks old spontaneous hypertension rats as the test model. Twenty five SHRs were randomized into five groups according to blood-pressure level. The group A is blank control group, the group B positive control group (Captopril), the group C (1.0 mg/kg), the group D (RDHP 10 mg/kg) and group E (RDHP 50 mg/kg). The administration approach is to fill in stomach by mouth. The blood pressure value was observed for each group. The long term oral administration design was conducted for one month. Twenty four SHRs were randomized into 3 groups. The first group is the blank control, the second group is low dose (RDHP 10 mg/kg) and the third group is high dose (RDHP 20 mg/kg). In administration period, blood pressure was measured for once a week.Outcomes: The once-oral administration animal experiments showed that the blood pressure of SHR drop was 11 mmHg, 17 mmHg, 26.00 mmHg, 17 mmHg at a dosage of 1 mg/kg, 10 mg/kg, 50 mg/kg hydrolysates and 1 mg/kg captopril, respectively, after I h administration. The results of long-term oral administration indicated that the blood pressure drop was 17 mmHg, 26 mmHg in 10 mg/kg and 20 mg/kg, respectively after 30 days administration. RDHP not only promoted the growth of SHR, but also had no adverse effect on heart rate.Conclusions: The present study indicated the inhibitory peptides from rice dreg hydrolysate had significant antihypertensive action and no other side effects by oral administration in SHR.

Transport, In Vivo Antihypertensive Effect, and Pharmacokinetics of an Angiotensin-Converting Enzyme (ACE) Inhibitory Peptide LVLPGE

An Angiotensin-Converting Enzyme Inhibitory Peptide LVLPGE Exerts an Antihypertensive Effect and Improves Endothelial Function Via Enos/no/cgmp Pathway

Antihypertensive Effect In Vivo Of Qaglspvr And Its Transepithelial Transport Through The Caco-2 Cell Monolayer

Antihypertensive Effects in Vitro and in Vivo of Novel Angiotensin-Converting Enzyme Inhibitory Peptides from Bovine Bone Gelatin Hydrolysate

Long-Term Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitory Peptide LAP

Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide

The effects of angiotensin I-converting enzyme inhibitory peptide VGINYW and the hydrolysate of -lactalbumin on blood pressure, oxidative stress and gut microbiota of spontaneously hypertensive rats

The effects of angiotensin I-converting enzyme inhibitory peptide VGINYW and the hydrolysate of α-lactalbumin on blood pressure, oxidative stress and gut microbiota of spontaneously hypertensive rats.

Hypotensive effect of potent angiotensin-I-converting enzyme inhibitory peptides from corn gluten meal hydrolysate: Gastrointestinal digestion and transepithelial transportation modifications

Effects of angiotensin-converting enzyme inhibitory peptide LAP on vascular remodeling.

Identification of novel angiotensin converting enzyme (ACE) inhibitory peptides from Pacific saury: In vivo antihypertensive effect and transport route

Antihypertensive Effects of Two Novel Angiotensin I-Converting Enzyme (ACE) Inhibitory Peptides from Gracilariopsis Lemaneiformis (rhodophyta) in Spontaneously Hypertensive Rats (Shrs).

Enhanced And Extended Anti-Hypertensive Effect Of Vp5 Nanoparticles

Study of screening, transport pathway, and vasodilation mechanisms on angiotensin-I converting enzyme inhibitory peptide from Ulva prolifera proteins

[Synthesis and Activity of ACE Inhibitory Peptides].

Effect of Angiotensin I-converting Enzyme Inhibitory Peptide from Rice Dregs Protein on Antihypertensive Activity in Spontaneously Hypertensive Rats.

The Antihypertensive Effect of Peptides: A Novel Alternative to Drugs?

Effects of high hydrostatic pressure treatment: Identification and characterization of snakehead-muscle-protein-based angiotensin-converting-enzyme-inhibitory peptides

Molecular Docking and Antihypertensive Effects of a Novel Angiotensin-I Converting Enzyme Inhibitory Peptide from Yak Bone

A Novel Angiotensin I-converting Enzyme Inhibitory Peptide from Phascolosoma Esculenta Water-Soluble Protein Hydrolysate

An efficient controlled release strategy for hypertension therapy: Folate-mediated lipid nanoparticles for oral peptide delivery